🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We see and feel the loss of talented EU students in postgraduate research (including postdocs). The high overseas student fees issue is somewhat mirrored for PhD students too. theguardian.com/education/2023…

Very excited to share our new pre-print: ‘A Single-cell Perturbation Landscape of Colonic Stem Cell Polarisation’ led by Xiao Qin and @FerranC96. (1/11) biorxiv.org/content/10.110…

#IStandWithGary

Daniel Royston and Jens Rittscher will refine & validate an #AI-based approach to #EarlyDetection and assessment of myeloproliferative #neoplasms to integrate into UK #clinical pathways [6/8]

Immigration of skilled workers supports both the NHS and British science. Both have already been negatively impacted by Brexit. This knee jerk bill will prevent essential recruitment into these professions and further degrades British success stories.

Our new study demonstrated real world difficulties in applying histological stratification tools in colitis-associated dysplasia, which remains very challenging. Congrats to Nadia Nasreddin who coordinated a wonderful group of expert pathologists. doi.org/10.1016/j.modp…

Pleased to present latest lab preprint showing how pathological disruption of intestinal BMP gradients gives rise to ectopic stem cell niches through stromal remodelling. biorxiv.org/cgi/content/sh…

Great flash talk by Holly Eggington Centre for Human Genetics on the potential of BMP4 activation for colorectal cancer prevention Oxford Cancer #PrevConf24

And huge congratulations to Holly Eggington for being the best early career researcher poster prize winner for the mechanistic theme!   A very worthy recipient of one of this year’s OxCODE travel awards! Oxford Cancer #PrevConf24

Inflammatory bowel disease (#IBD) increases bowel cancer risk: 1/3 of patients with low grade dysplasia (LGD) will get cancer. This risk is very high &reason for treatment. But also major conundrum b/c 2/3 patients with LGD won't get cancer. Can we know who is really at risk? 1/3

🚨RTs please🚨 Apply to join our spatial hackathon, full details below and the call is looking for applicants across a range of computational, biological and clinical disciplines. 👇👇

Fully deserved. Congrats stuey

Intense but exciting day for the CRC-STARS interview team at CRUK headquarters!

Congrats to the excellent Holly Eggington on completing her DPhil. Now just the MB part needed for the Dr Dr double! Many thanks to Philip Dunne and Sarah Blagden for examining

Best day ever!! Love you Basildihno ❤️❤️

Being forced to read the rantings of a megalomaniac is too much for even a very occasional user of this site. I’m done. See you at Kate Leedham-simon.bsky.social

So excited to get underway on CRC-STARS - a brilliant collaborative effort to improve therapies for colorectal cancer. Thanks to all the colleagues, patients and funders for helping us get here! news.cancerresearchuk.org/2025/03/31/5-5…